Wellgo Pharmaceuticals
Levosulpiride (75mg) + Esomeprazole (40mg)
Esomowel LS 75mg/40mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Esomowel LS 75mg/40mg Capsule SR is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux). It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Esomowel LS 75mg/40mg Capsule SR is to be taken empty stomach.
Esomowel LS 75mg/40mg Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole.
Do not consume alcohol while taking Esomowel LS 75mg/40mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Esomowel LS 75mg/40mg Capsule SR for longer than prescribed.
Store Esomowel LS 75mg/40mg Capsule SR in the original container, tightly closed. Dispose of unused medicine properly, ensuring it is not accessible to pets, children, or other individuals.
Take Esomowel LS 75mg/40mg Capsule SR as directed by your doctor. Ideally, take one capsule daily on an empty stomach to ensure optimal absorption and efficacy.
Patients with known allergies to any component or excipient of Esomowel LS 75mg/40mg Capsule SR should not use this medication.
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) when taking Esomowel LS 75mg/40mg Capsule SR. If you feel dizzy or lightheaded, rest for a while and resume once you feel better.
Research suggests that treatment with Esomowel LS 75mg/40mg Capsule SR may be linked to an elevated risk of osteoporosis-related fractures, particularly in the hip, wrist, or spine. This increased risk is associated with high doses and long-term therapy (one year or longer).